Search
AngioDynamics Inc
ANGOAdd to Watchlist
12.385USD
+0.235+1.93%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
516.23MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of AngioDynamics Inc is 8.00, ranking 66 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 17.00, with a high of 24.00 and a low of 16.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
18.667
Target Price
+53.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
AngioDynamics Inc
ANGO
4
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is AngioDynamics Inc's expected revenue for the next quarter?
AngioDynamics Inc's expected revenue is 80.40M.
What is AngioDynamics Inc's price target?
Analysts forecast that AngioDynamics Inc's price target is USD 17.00, with the highest forecast at USD 24.00 and the lowest forecast at USD 16.00.
How have AngioDynamics IncANGO's recent earnings per share performed?
The market expectation was USD -0.19, while AngioDynamics IncANGO's earnings per share (EPS) for the previous quarter was USD -0.15. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for AngioDynamics Inc?
Based on the ratings of AngioDynamics Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
